Metropolitan Life Insurance Company (MetLife)’s First Advantage FA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,921
Closed -$47.4K 732
2024
Q1
$47.4K Sell
2,921
-427
-13% -$6.96K ﹤0.01% 1431
2023
Q4
$55.5K Hold
3,348
﹤0.01% 1393
2023
Q3
$46.2K Buy
3,348
+447
+15% +$6.49K ﹤0.01% 1446
2023
Q2
$44.7K Sell
2,901
-461
-14% -$6.19K ﹤0.01% 1490
2023
Q1
$46.9K Sell
3,362
-504
-13% -$6.84K ﹤0.01% 1423
2022
Q4
$50.3K Hold
3,866
﹤0.01% 1468
2022
Q3
$49.6K Hold
3,866
﹤0.01% 1462
2022
Q2
$49K Hold
3,866
﹤0.01% 1531
2022
Q1
$78.1K Sell
3,866
-11,481
-75% -$198K ﹤0.01% 1356
2021
Q4
$292K Buy
15,347
+6,827
+80% +$132K ﹤0.01% 1754
2021
Q3
$162K Buy
+8,520
New +$179K ﹤0.01% 2240

Other funds holding FA

Metropolitan Life Insurance Company (MetLife)'s FA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of First Advantage (FA) in Q2 2024, closing a stake of 2,921 shares — an estimated $47.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FA in Q3 2021 and held it in 11 quarters. The position peaked at $292K in Q4 2021. 119 funds tracked by Wall St. Rank hold FA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining First Advantage position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,921 First Advantage shares in Q2 2024, an estimated $47.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in First Advantage in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s First Advantage position peaked at $292K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held First Advantage as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.